You are here

Chemotherapy Toxicity in the Elderly Task Force

The classes of drugs reviewed by the task force in the elderly setting included alkylators, antimetabolites, anthracyclines, taxanes, camptothecins, and epipodophyllotoxines. Data were found to be almost entirely lacking for patients older than 80 years. The conclusions and recommendations made are a consensus of the task force participants.

Task Force Members

Chair: Stuart  Lichtman, USA
Matti Aapro, Switzerland
Daniel Budman, USA
Etienne Chatelut, France
Vicki Morrison, USA
Iuliana Shapira, USA
Brigitte Tranchand, France
Hans Wildiers, Belgium


International Society of Geriatric Oncology Chemotherapy Taskforce: Evaluation of chemotherapy in older patients - An analysis of the medical literature. Lichtman SM et al. J Clin Oncol 2007; 25: 1832-43